eISSN: 2081-2841
ISSN: 1689-832X
Journal of Contemporary Brachytherapy
Current Issue Archive Supplements Articles in Press Journal Information Aims and Scope Editorial Office Editorial Board Register as Author Register as Reviewer Instructions for Authors Abstracting and indexing Subscription Advertising Information Links
SCImago Journal & Country Rank

Interview with Professor Janusz Skowronek
ABS 2015
vol. 10
Original paper

The effect of tandem-ovoid titanium applicator on points A, B, bladder, and rectum doses in gynecological brachytherapy using 192Ir

Mohammad Hosein Sadeghi, Sedigheh Sina, Amir Mehdizadeh, Reza Faghihi, Vahed Moharramzadeh, Ali Soleimani Meigooni

J Contemp Brachytherapy 2018; 10, 1: 91–95
Online publish date: 2018/02/28
View full text
Get citation
JabRef, Mendeley
Papers, Reference Manager, RefWorks, Zotero
The dosimetry procedure by simple superposition accounts only for the self-shielding of the source and does not take into account the attenuation of photons by the applicators. The purpose of this investigation is an estimation of the effects of the tandem and ovoid applicator on dose distribution inside the phantom by MCNP5 Monte Carlo simulations.

Material and methods
In this study, the superposition method is used for obtaining the dose distribution in the phantom without using the applicator for a typical gynecological brachytherapy (superposition-1). Then, the sources are simulated inside the tandem and ovoid applicator to identify the effect of applicator attenuation (superposition-2), and the dose at points A, B, bladder, and rectum were compared with the results of superposition. The exact dwell positions, times of the source, and positions of the dosimetry points were determined in images of a patient and treatment data of an adult woman patient from a cancer center. The MCNP5 Monte Carlo (MC) code was used for simulation of the phantoms, applicators, and the sources.

The results of this study showed no significant differences between the results of superposition method and the MC simulations for different dosimetry points. The difference in all important dosimetry points was found to be less than 5%.

According to the results, applicator attenuation has no significant effect on the calculated points dose, the superposition method, adding the dose of each source obtained by the MC simulation, can estimate the dose to points A, B, bladder, and rectum with good accuracy.


brachytherapy, tandem ovoid applicator, Monte Carlo simulations (MCNP5)

ICRU report 38. Dose and Volume Specification for Reporting Intracavitary Therapy in Gynaecology. International Commission on Radiation Units and Measurements, Bethesda 1985.
ICRU report 89. Prescribing, Recording, and Reporting Brachytherapy for Cancer of the Cervix. International Commission on Radiation Units and Measurements, Bethesda 2013.
Otter S, Franklin A, Ajaz M et al. Improving the efficiency of image guided brachytherapy in cervical cancer. J Contemp Brachytherapy 2016; 8: 557-565.
Fellner C, Pötter R, Knocke TH et al. Comparison of radiography and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects. Radiother Oncol 2001; 58: 53-62.
Huh H, Kim W, Loh JJ et al. Rectum dose analysis employing a multi-purpose brachytherapy phantom. Jap J Clin Oncol 2007; 37: 391-398.
Sina S, Faghihi R, Meigooni AS et al. Impact of the vaginal applicator and dummy pellets on the dosimetry parameters of Cs-137 brachytherapy source. J Appl Clin Med Phys 2011; 12: 3480.
Anagnostopoulos G, Baltas D, Karaiskos P et al. An analytical dosimetry model as a step towards accounting for inhomogeneities and bounded geometries in 192Ir brachytherapy treatment planning. Phys Med Biol 2003; 48: 1625-1647.
Casal E, Ballester F, Lluch JL et al. Monte Carlo calculations of dose rate distributions around the Amersham CDCS-M-type 137Cs source. Med Phys 2000; 27: 132-140.
Sina S, Faghihi R, Meigooni AS et al. Developing a Treatment Planning Software Based on TG-43U1 Formalism for Cs-137 LDR Brachytherapy. Iran Red Cresc Med J 2013; 15: 712.
Mesbahi A. Radial dose functions of GZP6 intracavitary brachytherapy 60 Co sources: treatment planning system versus Monte Carlo calculations. Iran J Radiat Res 2008; 5: 181-186.
Ochoa R, Gómez F, Ferreira IH et al. Design of a phantom for the quality control of high dose rate 192 Ir source used in brachytherapy. Radiother Oncol 2007; 82: 222-228.
Oyekunle EO, Obed RI, Akinlade BI et al. Comparison of doses to the rectum derived from treatment planning system with in-vivo dose values in vaginal vault brachytherapy using cylinder applicators. J Contemp Brachytherapy 2015; 7: 485-491.
Granero D, Vijande J, Ballester F et al. Dosimetry revisited for the HDR 192Ir brachytherapy source model mHDR-v2. Med Phys 2011; 38: 487-494.
Glasgow GP, Dillman LT. Specific gamma-ray constant and exposure rate constant of 192Ir. Med Phys 1979; 6: 49-52.
Briesmeister JF. MCNPTM-A general Monte Carlo N-particle transport code. Version 4C, LA-13709-M, Los Alamos National Laboratory, 2000; 2.
Yu PC, Chao TC, Lee CC et al. A Monte Carlo dosimetry study using Henschke applicator for cervical brachytherapy. Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment 2010; 619: 411-414.
Kapp KS, Stuecklschweiger GF, Kapp DS et al. Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques. Radiother Oncol 1992; 24: 137-146.
Schoeppel SL, Lavigne ML, Martel MK et al. Three-dimensional treatment planning of intracavitary gynecologic implants: Analysis of ten cases and implications for dose specification. Int J Radiat Oncol Biol Phys 1994; 28: 277-283.
Gifford KA, Mourtada F, Cho SH et al. Monte Carlo calculations of the dose distribution around a commercial gynecologic tandem applicator. Radiother Oncol 2005; 77: 210-215.
Tanderup K, Hellebust TP, Lang S et al. Consequences of random and systematic reconstruction uncertainties in 3D image-based brachytherapy in cervical cancer. Radiother Oncol 2008; 89: 156-163.
Hellebust TP, Kirisits C, Berger D et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010; 96: 153-160.
Kertzscher G, Andersen CE, Siebert F-A et al. Identifying afterloading PDR and HDR brachytherapy errors using real-time fiber-coupled Al 2 O 3: C dosimetry and a novel statistical error decision criterion. Radiother Oncol 2011; 100: 456-462.
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe